MASSACHUSETTS GENERAL HOSPITAL
Department of Pharmacy
Department of Nursing
General Care
Generic Name: |
Alteplase |
Trade Name: |
Activase |
Action: |
Tissue Plasminogen Activator (tPA) |
Indications: |
Peripheral venous thrombosis Catheter occlusion |
Administration Guidelines: |
|
Usual Dosage Range and Route: |
Catheter occlusion Patients <30 kg: 110% of the internal lumen volume of the catheter, not to exceed 2 mg/2 mL; retain in catheter for 0.5-2 hours; may instill a second dose if catheter remains occluded Patients =30 kg: 2 mg (2 mL); retain in catheter for 0.5-2 hours; may instill a second dose if catheter remains occluded Restoration of PICC lines may be implemented only by an IV Nurse
Catheter occlusion with fibrin sheath- 4 hour continuous infusion Infusion: 0.5 mg/hr for 4 hours. See special considerations for post infusion.
Peripheral Venous Thrombosis-Systemic Thrombolysis Approach Loading dose: None Infusion: 0.5-4 mg/h for 24 h (recommended max 50mg/24 hours) Heparin should be started after altepase infusion is completed (no loading dose) to maintain the aPTT in a therapeutic range .
Peripheral Venous Thrombosis-Catheter-directed Thrombolysis Initial Or Loading Dose Must Be Administered By Physician Loading dose: 4-10mg administered during procedure Maintenance Infusion: 0.5-4mg/hr for 4-24 hours IV. Recommended cumulative maximum of 50 mg (Load plus infusion). Heparin should be used at a low non-weight adjusted dose (eg 250 units/hr) keeping aPTT <1.5 times baseline during alteplase infusion.
|
Standard Concentration: |
Catheter occlusion: 2mg/2mL (Cathflo) - Add 2.2 mL sterile water for injection to vial. DO NOT use bacteriostatic water.Mix gently until contents are dissolved. DO NOT shake. Final concentration: 1 mg/mL. Peripheral venous thrombosis: 50mg/500mL, 25mg/250mL Catheter occlusion with fibrin sheath -4mg/80mL NS |
Suggested Maximum Dose: |
Total 24 hour dose not to exceed 100 mg for infusions |
Special Considerations: |
Catheter occlusion: - Instill and let dwell for 30 minutes. Do not force solution into catheter. -leave syringe in place and do not close clamps on the catheter t allow the t-Pa to move freely into the catheter as the fibrin dissolves. -Aspirate for blood return. If catheter is functional aspirate and discard 4-5 mL of blood for patients > 10 kg or 3 mL of blood from patients < 10 kg to remove the medication and residual clot. -Gently irrigate the catheter with normal saline flush. -If catheter is non functional after 30 minute dwell, continue to allow t-PA to dwell for up to 2 hours- then aspirate for blood return. If catheter still not functional withdraw instilled solution. May instill second dose. -On rare occasions the t-Pa dose may not be aspirated, but flushing of catheter may be possible. Infusions: - Infusion should not be interrupted and should not be administered in the same IV line as other medications. - Avoid intramuscular injections and vascular punctures at non-compressible sites before, during and after therapy. - Check neuro vital signs every 2 hours. - Contraindicated in patients with recent trauma, hemorrhagic stroke, surgery, active GI bleed within 2 months, coagulopathy or known bleeding diathesis. - Should be used with caution in patients who have received chest compressions. - Should be used with caution in patients who are currently on Heparin, Coumadin or antiplatelet drugs -Peripheral venous thrombosis; Check fibrinogen levels every 6 hours and consider holding when less than 100 mg/dl |
Precautions and Side Effects for infusions: |
- Hemorrhage, bleeding from iv sites - Fever - Hypotension - Reperfusion arrhythmias - Anaphylaxis -Hemorrhagic stroke |
rev: 02/09